| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Seung-Hee Yoo | |
| Kazunari Nohara | |||
| Zheng (Jake) Chen | |||
| P2860 | cites work | A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk | Q34897205 |
| Selective inhibition of casein kinase 1 epsilon minimally alters circadian clock period | Q34982171 | ||
| Circadian rhythms, sleep, and metabolism | Q35015762 | ||
| Intracellular and intercellular processes determine robustness of the circadian clock. | Q35051662 | ||
| Association of prescription H1 antihistamine use with obesity: results from the National Health and Nutrition Examination Survey | Q35565012 | ||
| Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index | Q21144740 | ||
| High-throughput chemical screen identifies a novel potent modulator of cellular circadian rhythms and reveals CKIα as a clock regulatory kinase | Q21563543 | ||
| The Efficacy of Light Therapy in the Treatment of Mood Disorders: A Review and Meta-Analysis of the Evidence | Q22306277 | ||
| Impact of sleep debt on metabolic and endocrine function | Q23731787 | ||
| Modeling of a human circadian mutation yields insights into clock regulation by PER2 | Q24292897 | ||
| Dec1 and Dec2 are regulators of the mammalian molecular clock | Q24313082 | ||
| Competing E3 ubiquitin ligases govern circadian periodicity by degradation of CRY in nucleus and cytoplasm | Q24321406 | ||
| PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues | Q24568134 | ||
| NEMO/NLK phosphorylates PERIOD to initiate a time-delay phosphorylation circuit that sets circadian clock speed | Q24594785 | ||
| Diminished brain glucose metabolism is a significant determinant for falling rates of systemic glucose utilization during sleep in normal humans | Q24609701 | ||
| Genetics of sleep and sleep disorders | Q24619903 | ||
| Circadian clocks in human red blood cells | Q24620753 | ||
| Obesity and metabolic syndrome in circadian Clock mutant mice | Q24627935 | ||
| Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists | Q24629345 | ||
| Peroxiredoxins are conserved markers of circadian rhythms | Q24631336 | ||
| The transcriptional repressor DEC2 regulates sleep length in mammals | Q24634596 | ||
| CLOCK and NPAS2 have overlapping roles in the suprachiasmatic circadian clock | Q24650981 | ||
| A genome-wide RNAi screen for modifiers of the circadian clock in human cells | Q24655808 | ||
| Adverse metabolic and cardiovascular consequences of circadian misalignment | Q24656239 | ||
| The effects of light at night on circadian clocks and metabolism | Q34412362 | ||
| Time-restricted feeding is a preventative and therapeutic intervention against diverse nutritional challenges | Q34451866 | ||
| Clues to the functions of mammalian sleep | Q34463191 | ||
| Small molecule modifiers of circadian clocks. | Q34480532 | ||
| Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat. | Q34506885 | ||
| NPAS2 as a transcriptional regulator of non-rapid eye movement sleep: genotype and sex interactions | Q34598608 | ||
| Post-translational modifications regulate the ticking of the circadian clock. | Q34605395 | ||
| The mouse Clock mutation reduces circadian pacemaker amplitude and enhances efficacy of resetting stimuli and phase-response curve amplitude | Q34657918 | ||
| Metabolism and the control of circadian rhythms | Q34667432 | ||
| Sleep, feeding, and neuropeptides: roles of orexins and orexin receptors. | Q34671522 | ||
| Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis | Q24658408 | ||
| Differential effects of PER2 phosphorylation: molecular basis for the human familial advanced sleep phase syndrome (FASPS) | Q24669751 | ||
| The metabolic consequences of sleep deprivation | Q24681664 | ||
| Genetic basis of human circadian rhythm disorders | Q26865668 | ||
| Melatonin secretion and the incidence of type 2 diabetes | Q27277216 | ||
| Disturbed clockwork resetting in Sharp-1 and Sharp-2 single and double mutant mice | Q27300842 | ||
| An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome | Q27863695 | ||
| NPAS2: an analog of clock operative in the mammalian forebrain | Q27863700 | ||
| Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome | Q27863810 | ||
| CKIepsilon/delta-dependent phosphorylation is a temperature-insensitive, period-determining process in the mammalian circadian clock | Q27865241 | ||
| The circadian clock mutation alters sleep homeostasis in the mouse | Q28142164 | ||
| The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo | Q28206180 | ||
| High sensitivity of the human circadian melatonin rhythm to resetting by short wavelength light | Q28206531 | ||
| Coordinated transcription of key pathways in the mouse by the circadian clock | Q28217978 | ||
| Entrainment of disrupted circadian behavior through inhibition of casein kinase 1 (CK1) enzymes | Q28290094 | ||
| Is there an association between shift work and having a metabolic syndrome? Results from a population based study of 27,485 people | Q28361758 | ||
| Sleep duration and chronic diseases among U.S. adults age 45 years and older: evidence from the 2010 Behavioral Risk Factor Surveillance System | Q28388571 | ||
| Human blood metabolite timetable indicates internal body time | Q28388632 | ||
| Metabolic effects of sleep disruption, links to obesity and diabetes | Q28390294 | ||
| Differential functions of mPer1, mPer2, and mPer3 in the SCN circadian clock | Q28509438 | ||
| Altered sleep and behavioral activity phenotypes in PER3-deficient mice | Q28510370 | ||
| Preventing olanzapine-induced weight gain using betahistine: a study in a rat model with chronic olanzapine treatment | Q28541531 | ||
| Poly(ADP-ribose) polymerase 1 participates in the phase entrainment of circadian clocks to feeding | Q28587849 | ||
| Altered patterns of sleep and behavioral adaptability in NPAS2-deficient mice | Q28588185 | ||
| Circadian system, sleep and endocrinology | Q28741151 | ||
| Rotating night shift work and risk of type 2 diabetes: two prospective cohort studies in women | Q28741820 | ||
| Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite | Q29615447 | ||
| Transcriptional architecture and chromatin landscape of the core circadian clock in mammals | Q29616252 | ||
| Early aging and age-related pathologies in mice deficient in BMAL1, the core componentof the circadian clock | Q29616363 | ||
| The genetics of mammalian circadian order and disorder: implications for physiology and disease | Q29616366 | ||
| Hypothalamic regulation of sleep and circadian rhythms | Q29619151 | ||
| Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1 | Q29619241 | ||
| Identification of diverse modulators of central and peripheral circadian clocks by high-throughput chemical screening | Q35657707 | ||
| Circadian clocks, clock networks, arylalkylamine N-acetyltransferase, and melatonin in the retina. | Q36104128 | ||
| Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways | Q36138183 | ||
| Short sleep duration, glucose dysregulation and hormonal regulation of appetite in men and women | Q36304792 | ||
| Genetic insights on sleep schedules: this time, it's PERsonal | Q36405856 | ||
| The pineal gland and melatonin in relation to aging: a summary of the theories and of the data | Q36681216 | ||
| Impact of insufficient sleep on total daily energy expenditure, food intake, and weight gain | Q36747529 | ||
| Central and peripheral clocks in cardiovascular and metabolic function | Q36793666 | ||
| Sleep and circadian rhythms: key components in the regulation of energy metabolism | Q36914056 | ||
| Small-molecule screen in adult Drosophila identifies VMAT as a regulator of sleep | Q36915707 | ||
| Mammalian circadian signaling networks and therapeutic targets. | Q36944717 | ||
| A conserved DNA damage response pathway responsible for coupling the cell division cycle to the circadian and metabolic cycles | Q37000314 | ||
| Aging in the circadian system: considerations for health, disease prevention and longevity | Q37085998 | ||
| Functional identification of the mouse circadian Clock gene by transgenic BAC rescue | Q37150579 | ||
| A review of nighttime eating disorders | Q37280190 | ||
| Genetics of sleep. | Q37317011 | ||
| Food-entrained circadian rhythms are sustained in arrhythmic Clk/Clk mutant mice. | Q37335227 | ||
| Molecular clock is involved in predictive circadian adjustment of renal function | Q37364174 | ||
| How to fix a broken clock | Q37375901 | ||
| Behavioral intervention versus pharmacotherapy or their combinations in the management of overactive bladder dysfunction | Q37484824 | ||
| Circadian clock genes and sleep homeostasis. | Q37497516 | ||
| Integrative neurobiology of energy homeostasis-neurocircuits, signals and mediators | Q37591577 | ||
| Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice | Q37657495 | ||
| Therapeutic interventions to reduce the risk of progression from prediabetes to type 2 diabetes mellitus | Q37660219 | ||
| Obesity and shift work: chronobiological aspects. | Q37685290 | ||
| Sleep and Alzheimer disease pathology--a bidirectional relationship | Q37691522 | ||
| Systemic and cellular reflections on ageing and the circadian oscillator: a mini-review | Q37803488 | ||
| New evidence for a role of melatonin in glucose regulation | Q37812859 | ||
| Understanding systems-level properties: timely stories from the study of clocks | Q37873714 | ||
| Sleep disturbances and insulin resistance | Q37939268 | ||
| Neural circuitry engaged by prostaglandins during the sickness syndrome | Q38029970 | ||
| The circadian clock gene Csnk1e regulates rapid eye movement sleep amount, and nonrapid eye movement sleep architecture in mice. | Q38586624 | ||
| Circadian variation and triggers of onset of acute cardiovascular disease | Q38608823 | ||
| Sleep deprivation in the rat: X. Integration and discussion of the findings | Q38612198 | ||
| Optimized chemical probes for REV-ERBα. | Q39154797 | ||
| High-throughput screening and chemical biology: new approaches for understanding circadian clock mechanisms. | Q39516241 | ||
| Dim light at night disrupts molecular circadian rhythms and increases body weight | Q39930769 | ||
| Circadian disruption leads to insulin resistance and obesity | Q41224916 | ||
| Why we sleep: the temporal organization of recovery | Q42109659 | ||
| Effect of shift work on body mass index and metabolic parameters. | Q42166810 | ||
| Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome. | Q42783953 | ||
| Ramelteon attenuates age-associated hypertension and weight gain in spontaneously hypertensive rats. | Q42969539 | ||
| Clock genes and sleep homeostasis: a fundamental link within the two-process model? | Q43248240 | ||
| Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity. | Q44582392 | ||
| Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics. | Q44877798 | ||
| Piromelatine, a novel melatonin receptor agonist, stabilizes metabolic profiles and ameliorates insulin resistance in chronic sleep restricted rats | Q45361851 | ||
| NEU-P11, a novel melatonin agonist, inhibits weight gain and improves insulin sensitivity in high-fat/high-sucrose-fed rats. | Q46017671 | ||
| Association of body mass index with lifestyle and rotating shift work in Japanese female nurses | Q46230596 | ||
| Activation of TGF-beta/activin signalling resets the circadian clock through rapid induction of Dec1 transcripts | Q46231033 | ||
| Olanzapine (LY170053, 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine), but not the novel atypical antipsychotic ST2472 (9-piperazin-1-ylpyrrolo[2,1-b][1,3]benzothiazepine), chronic administration induces weight gain, hyper | Q46528841 | ||
| Light activates the adrenal gland: timing of gene expression and glucocorticoid release | Q46791849 | ||
| A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial | Q46879925 | ||
| Association study of GABAA α2 receptor subunit gene variants in antipsychotic-associated weight gain | Q47418258 | ||
| Obesity = physical activity + dietary intake + sleep stages + light exposure | Q48089944 | ||
| Circadian rhythms: a tale of two nuclei | Q48397990 | ||
| Sleep homeostasis in suprachiasmatic nuclei-lesioned rats: effects of sleep deprivation and triazolam administration | Q48432719 | ||
| Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity | Q48691942 | ||
| Ventromedial arcuate nucleus communicates peripheral metabolic information to the suprachiasmatic nucleus | Q48757989 | ||
| Zolpidem-induced changes in activity, metabolism, and anxiety in rats. | Q50652394 | ||
| Protective effects of melatonin against metabolic and reproductive disturbances in polycystic ovary syndrome in rats. | Q51116612 | ||
| Restriction of DNA replication to the reductive phase of the metabolic cycle protects genome integrity. | Q52580091 | ||
| Light suppresses melatonin secretion in humans | Q54294567 | ||
| Neural Connections of Hypothalamic Neuroendocrine Nuclei in the Rat | Q60056600 | ||
| Melatonin improves metabolic syndrome induced by high fructose intake in rats | Q83181848 | ||
| Circadian rhythms, the molecular clock, and skeletal muscle | Q84213769 | ||
| Central administration of an orexin receptor 1 antagonist prevents the stimulatory effect of Olanzapine on endogenous glucose production | Q87052342 | ||
| Circadian integration of metabolism and energetics | Q29619638 | ||
| The meter of metabolism | Q29619740 | ||
| Sleep drives metabolite clearance from the adult brain | Q29620065 | ||
| Effects of poor and short sleep on glucose metabolism and obesity risk | Q30409888 | ||
| Intercellular coupling confers robustness against mutations in the SCN circadian clock network | Q30543329 | ||
| Small-molecule antagonists of melanopsin-mediated phototransduction. | Q30557746 | ||
| The selective orexin receptor 1 antagonist ACT-335827 in a rat model of diet-induced obesity associated with metabolic syndrome | Q30560872 | ||
| Pharmacological targeting of the mammalian clock regulates sleep architecture and emotional behaviour | Q30657215 | ||
| Circadian orchestration of the hepatic proteome | Q33245770 | ||
| Harmonics of circadian gene transcription in mammals | Q33426339 | ||
| Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation | Q33523962 | ||
| Sleep homeostasis and models of sleep regulation | Q33822213 | ||
| H1-antihistamines exacerbate high-fat diet-induced hepatic steatosis in wild-type but not in apolipoprotein E knockout mice. | Q33913281 | ||
| Entrainment of free-running circadian rhythms by melatonin in blind people | Q33921061 | ||
| Rhythmic leptin is required for weight gain from circadian desynchronized feeding in the mouse | Q34031939 | ||
| Suprachiasmatic nucleus: cell autonomy and network properties | Q34098176 | ||
| Circadian clock genes: non-circadian roles in sleep, addiction, and psychiatric disorders? | Q34105869 | ||
| Anorectic, thermogenic and anti-obesity activity of a selective orexin-1 receptor antagonist in ob/ob mice | Q34112881 | ||
| Stress response genes protect against lethal effects of sleep deprivation in Drosophila | Q34128865 | ||
| Temperature as a universal resetting cue for mammalian circadian oscillators | Q34143703 | ||
| Association of sleep duration with chronic diseases in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study | Q34147726 | ||
| Screening of clock gene polymorphisms demonstrates association of a PER3 polymorphism with morningness-eveningness preference and circadian rhythm sleep disorder | Q34153111 | ||
| Bright light resets the human circadian pacemaker independent of the timing of the sleep-wake cycle | Q34188646 | ||
| Acute melatonin administration in humans impairs glucose tolerance in both the morning and evening. | Q34238369 | ||
| The circadian clock and pathology of the ageing brain | Q34259247 | ||
| Timing of human sleep: recovery process gated by a circadian pacemaker | Q34266646 | ||
| Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet | Q34275922 | ||
| Light at night increases body mass by shifting the time of food intake | Q34276797 | ||
| Identification of small molecule activators of cryptochrome | Q34288305 | ||
| Circadian topology of metabolism | Q34311679 | ||
| Mice genetically deficient in vasopressin V1a and V1b receptors are resistant to jet lag. | Q34375176 | ||
| Impact of the human circadian system, exercise, and their interaction on cardiovascular function | Q34377388 | ||
| Relationships between sleep quality and glucose regulation in normal humans | Q34393607 | ||
| REV-ERB and ROR nuclear receptors as drug targets. | Q34407313 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | circadian rhythm | Q208353 |
| metabolic disease | Q2351083 | ||
| sleep | Q35831 | ||
| P304 | page(s) | 35 | |
| P577 | publication date | 2015-03-23 | |
| P1433 | published in | Frontiers in Endocrinology | Q27723680 |
| P1476 | title | Manipulating the circadian and sleep cycles to protect against metabolic disease | |
| P478 | volume | 6 |
| Q89531625 | A CLOCK-binding small molecule disrupts the interaction between CLOCK and BMAL1 and enhances circadian rhythm amplitude |
| Q50527602 | A Filtration-based Method of Preparing High-quality Nuclei from Cross-linked Skeletal Muscle for Chromatin Immunoprecipitation. |
| Q42200145 | Ammonia-lowering activities and carbamoyl phosphate synthetase 1 (Cps1) induction mechanism of a natural flavonoid |
| Q37699510 | Clock-Enhancing Small Molecules and Potential Applications in Chronic Diseases and Aging |
| Q30382902 | Daily Eating Patterns and Their Impact on Health and Disease. |
| Q51793703 | Development and Therapeutic Potential of Small-Molecule Modulators of Circadian Systems. |
| Q30238803 | Development of a Behavioral Sleep Intervention as a Novel Approach for Pediatric Obesity in School-aged Children |
| Q59277879 | Development of a Behavioral Sleep Intervention as a Novel Approach for Pediatric Obesity in School-aged Children |
| Q35905811 | Dual attenuation of proteasomal and autophagic BMAL1 degradation in Clock Δ19/+ mice contributes to improved glucose homeostasis |
| Q89402889 | Emerging relevance of circadian rhythms in headaches and neuropathic pain |
| Q52382066 | Heritability of the timing of food intake. |
| Q36779787 | Molecular Targets for Small-Molecule Modulators of Circadian Clocks |
| Q42608943 | Period2 3'-UTR and microRNA-24 regulate circadian rhythms by repressing PERIOD2 protein accumulation. |
| Q33816685 | Regulation of transforming growth factor-beta1 (TGF-β1)-induced pro-fibrotic activities by circadian clock gene BMAL1. |
| Q49510244 | Temporal Control of Metabolic Amplitude by Nocturnin |
| Q60949658 | The Role of RNA Editing in Cancer Development and Metabolic Disorders |
| Q40204797 | The Small Molecule Nobiletin Targets the Molecular Oscillator to Enhance Circadian Rhythms and Protect against Metabolic Syndrome. |
| Q39313687 | The brain, sirtuins, and ageing |
Search more.